A bench to bedside approach to improving treatment of blinding retinal diseases

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1005332

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

I am a retinal specialist and clinician scientist directing a group dedicated to identifying improved treatments for blinding macular disease. My clinical research unit conducts randomised clinical trials and pioneered the use of intraocular steroid therapy. My Laboratory research group is interested in stem cell therapy, proteomic analysis of macular disease and the role of Muller cell dysfunction in retinal vascular disease.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2015

Funding Scheme: Practitioner Fellowship

Funding Amount: $452,051.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical trial | corticosteroids | diabetic retinopathy | macular disease | proteomics | stem cells | therapeutic drug monitoring | therapeutics

Related Links